UniProt ID ▼ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7K9H6A4 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7K9H571 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K9H558 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7K9H4B7 | Angiotensin-converting enzyme (Fragment) |
|
1 | 0 |
|
A0A7K9H390 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7K9H114 | Phosphoinositide phospholipase C (Fragment) |
|
2 | 0 |
|
A0A7K9H0B7 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9H0A5 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K9GYS5 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K9GXV2 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9GWB6 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K9GUW4 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7K9GPC1 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K9GM31 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K9GLA7 | Angiotensin-converting enzyme (Fragment) |
|
4 | 0 |
|
A0A7K9GG51 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K9GFM0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K9GFB6 | AMD monooxygenase (Fragment) |
|
1 | 0 |
|
A0A7K9GC14 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7K9GB81 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9GB51 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9GB46 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K9GAK1 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7K9G819 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K9G715 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024